Qinchuan Wu

发表

Blocking Triggering Receptor Expressed on Myeloid Cells‐1‐Positive Tumor‐Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti‐Programmed Cell Death Ligand 1 Resistance in Liver Cancer

Haiyang Xie, Lin Zhou, Shusen Zheng, 2019, Hepatology.

Combination with Toll-like receptor 4 (TLR4) agonist reverses GITR agonism mediated M2 polarization of macrophage in Hepatocellular carcinoma

Kecheng Zhang, Shusen Zheng, Rong Su, 2022, Oncoimmunology.

Blocking exposed PD-L1 elicited by nanosecond pulsed electric field reverses dysfunction of CD8+ T cells in liver cancer.

Haiyang Xie, Lin Zhou, Shusen Zheng, 2020, Cancer letters.

PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma

Haiyang Xie, Lin Zhou, Shusen Zheng, 2018, Journal of Experimental & Clinical Cancer Research.

Blocking CD47 promotes anti-tumor immunity through CD103+ dendritic cell-NK cell axis in murine hepatocellular carcinoma model.

Haiyang Xie, Shusen Zheng, Rong Su, 2022, Journal of hepatology.

YAP promotes multi-drug resistance and inhibits autophagy-related cell death in hepatocellular carcinoma via the RAC1-ROS-mTOR pathway

Lin Zhou, Shusen Zheng, Wu-hua Zhou, 2019, Cancer Cell International.

Dual-function of Baicalin in nsPEFs-treated Hepatocytes and Hepatocellular Carcinoma cells for Different Death Pathway and Mitochondrial Response

Lin Zhou, Shusen Zheng, Wu-hua Zhou, 2019, International journal of medical sciences.

YAP promotes multi-drug resistance and inhibits autophagy-related cell death in hepatocellular carcinoma via the RAC1-ROS-mTOR pathway

Lin Zhou, Shusen Zheng, Wu-hua Zhou, 2019, Cancer Cell International.

Blocking Triggering Receptor Expressed on Myeloid Cells‐1‐Positive Tumor‐Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti‐Programmed Cell Death Ligand 1 Resistance in Liver Cancer

Haiyang Xie, Lin Zhou, Shusen Zheng, 2019, Hepatology.

Full-Right Full-Left Split Liver Transplantation for Two Adult Recipients: A Single-Center Experience in China

Shusen Zheng, Wu Zhang, Zhe Yang, 2023, Journal of clinical medicine.

Blocking MARCO+ tumor-associated macrophages improves anti-PD-L1 therapy of hepatocellular carcinoma by promoting the activation of STING-IFN type I pathway.

Rong Su, Danjing Guo, Junjie Qian, 2023, Cancer letters.

Targeting neuropilin-1 abolishes anti-PD-1-upregulated regulatory T cells and synergizes with 4-1BB agonist for liver cancer treatment

Shusen Zheng, Jieyi Wang, Wu-hua Zhou, 2023, Hepatology.

Lenvatinib enhances antitumor immunity by promoting the infiltration of TCF1 + CD8 + T cells in HCC via blocking VEGFR2

Junjie Qian, Shuai Wang, Lin Zhou, 2023, Cancer science.